🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Changing gears, Dr. Timothy McKinsey from CU Anschutz Medical Campus CU School of Medicine is describing his innovative #Epigenetics approach to HFpEF: approaches targeting histone acetylation at the AHAMeetings 2018 AHA Scientific Sessions! #WhatsAnHDAC #AHA18

Dr. Roger Foo from NUS is sharing his research about cardiovascular single cell epigenomes at the AHAMeetings 2018 Scientific Sessions. #Epigenetics #AHA18

Dr. Thomas Thum from Leibniz Uni Hannover is making sense of the mystifying world of non-coding RNAs at the AHAMeetings 2018 Scientific Sessions! #2Smart #ElegantApproaches #AHA18

Soestalol inhibited outward IhERG tail current density in a manner similar to conventional sotalol. Drs. Tyler Shugg, et al. suggest "results warrant further assessment of soestalol as a short-acting, Class III antiarrhythmic drug." Read in #JACCCEP: bit.ly/2Dj7Nq2l

Letrozole targets the human ether‐a‐go‐go–related gene potassium current in glioblastoma New study by Tyler Shugg and @Assiri116 #BasClinPharmTox #clinicalpharmacology onlinelibrary.wiley.com/doi/full/10.11…

.Tyler Shugg et al show potential of precision medicine in patients at IU Simon Comprehensive Cancer Center. Approximately one in seven patients w/ advanced cancer had an opportunity for actionable pharmacogenetics during the study period (median follow-up: 2.9 years). fal.cn/3nlU6

The All of Us Research Hub, a publicly available research database that contains electronic health record, genomic and wearable technology data from 372,000+ participants, is now accessible. You can register to use this exciting resource at: researchallofus.org

THE PK/PD/PG PRN is an active group of clinical pharmacists and pharmacist-scientists with interests in precision medicine. We invite pharmacists with similar interests to join our network. We have exciting events planned for the coming year! #pharmacist #precisionmedicine

It's our pleasure to spotlight Linda Awdishu, PharmD, MAS, Professor and Chair of the Division of Clinical Pharmacy at the University of California, San Diego School of Pharmacy. Expert members like Dr. Awdishu are what make the PK/PD/PG PRN great! #pharmacists #precisionmedicine

New #research from ACCP PK/PD/PG PRN members Teresa Ho, @roseanngammal, and Mark Dunnenberger addresses the important topic of effective patient counseling approaches when communicating panel-based #pharmacogenetics results. Full article available at: academic.oup.com/ajhp/advance-a…

Tyler Shugg, PhD (Tyler Shugg), shares research on severe sunitinib- and axitinib-induced cardiomyopathy in a patient with genetic variants associated with familial cardiomyopathy and reduced CYP3A function. Indiana University Research IU School of Medicine

New Research: Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer: Introduction Drug-induced prolongation of the heart rate-corrected QT interval (QTc) is associated with increased… frontiersin.org/articles/10.33… #cardiovascular

Our own Drs. Tyler Shugg, Bryan Schneider, Todd Skaar, and colleagues demonstrate that prescriptions for QT-prolonging drugs were associated with longer corrected QT interval measurements and increased odds of being excluded from cancer clinical trials. 🔗ow.ly/iiyG50MnQUt

We are hiring! Please spread the word! ⁦IU School of Medicine Department of Medicine⁩ #ClinPharm. Come join a group of vibrant investigators doing research to discover and develop novel innovative personalized therapeutics in beautiful #Indy indiana.peopleadmin.com/postings/22766